Basket | Login

 
 
 
 

Phase II trials

Clinical Trials Watch

This section contains information about clinical trials that are:

  • Currently recruiting participants
  • Conducted at least in one European country
  • In phase II (in these trials the drug / treatment is tested in groups involving up to several hundred participants with the disease/condition. These trials are conducted to explore the therapeutic efficacy of the drug / treatment in participants.)

How many Phase II trials are reported in the CTW?

The CTW reports currently 10 ongoing Phase II clinical trials recruiting participants in Europe. These trials are listened in the table below:

Study

Study sponsor

Name of the drug

Condition

ACI-35-1802

AC Immune

ACI-35.030 or JACI-35.054

Early Alzheimer's disease

ALZ-801

Alzheon Inc.

ALZ-801

Early Alzheimer's disease

AUTONOMY

Janssen

JNJ-63733657

Early Alzheimer's disease

Brainshuttle AD

Hoffmann-La Roche

RO7126209

Prodromal or mild to moderate Alzheimer's disease

DESPIAD

University College London

CPHPC

Mild Alzheimer's disease

GRADUATION

Roche

Gantenerumab 

Early Alzheimer's disease 

INFRONT2

Alector

AL001

Frontotemporal dementia

INVOKE-2

Alector

AL002

Early Alzheimer's disease 

TRAILBLAZER-ALZ 2

Eli Lilly

Donanemab

Early Alzheimer's disease

VIVIAD

Vivoryon Therapeutics AG

PQ912

Mild cognitive impairment and mild dementia due to Alzheimer 's Disease

 

 
 

Last Updated: Wednesday 14 July 2021

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options